Effects of Atrial Fibrillation on Long-Term Prognosis of Patients with Multiple Nonlacunar Cerebral Infarctions
DING Yarong, YAN Hongyi
Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, China; China National Clinical Research Center for Neurological Diseases, Beijing 100070, China
DING Yarong, YAN Hongyi. Effects of Atrial Fibrillation on Long-Term Prognosis of Patients with Multiple Nonlacunar Cerebral Infarctions[J]. Chinese Journal of Stroke, 2024, 19(12): 1419-1425.
[1]WANG W Z,JIANG B,SUN H X,et al. Prevalence,incidence,and mortality of stroke in China:results from a nationwide population-based survey of 480 687 adults[J]. Circulation,2017,135(8):759-771.
[2] GUO J H,LI Z X,GU H Q,et al. Prevalence,risk factors and prognostic value of atrial fibrillation detected after stroke after haemorrhagic versus ischaemic stroke[J/OL]. Stroke Vasc Neurol,2024,svn-2023-002974[2024-08-09]. http://doi.org/10.1136/svn-2023-002974.
[3] MORSETH B,GEELHOED B,LINNEBERG A,et al. Age-specific atrial fibrillation incidence,attributable risk factors and risk of stroke and mortality:results from the MORGAM consortium[J/OL]. Open Heart,2021,8(2):e001624[2024-08-09]. https://doi.org/10.1136/openhrt-2021-001624.
[4] CHENG S Y,HE J Z,HAN Y C,et al. Global burden of atrial fibrillation/atrial flutter and its attributable risk factors from 1990 to 2021[J/OL]. Europace,2024,26(7):euae195[2024-09-01]. https://doi.org/10.1093/europace/euae195.
[5] HART R G,DIENER H C,COUTTS S B,et al. Embolic strokes of undetermined source:the case for a new clinical construct[J]. Lancet Neurol,2014,13(4):429-438.
[6] WANG Y J,JING J,MENG X,et al. The third China national stroke registry(CNSR-Ⅲ)for patients with acute ischaemic stroke or transient ischaemic attack:design,rationale and baseline patient characteristics[J]. Stroke Vasc Neurol,2019,4(3):158-164.
[7] JING J,YANG X M,WU Y Y,et al. A score to predict the stroke recurrence of patients with embolic stroke of undetermined source[J]. J Neurol,2022,269(12):6428-6435.
[8] ESCUDERO-MARTÍNEZ I,MORALES-CABA L,SEGURA T. Atrial fibrillation and stroke:a review and new insights[J]. Trends Cardiovasc Med,2023,33(1):23-29.
[9] ELSHEIKH S,HILL A,IRVING G,et al. Atrial fibrillation and stroke:state-of-the-art and future directions[J/OL]. Curr Probl Cardiol,2024,49(1 Pt C):102181[2024-09-01]. https://doi.org/10.1016/j.cpcardiol.2023.102181.
[10] WATANABE K,OKAZAKI S,KITANO T,et al. Stroke severity and outcomes in patients with newly diagnosed atrial fibrillation[J/OL]. Front Neurol,2021,12:666491[2024-09-01]. https://doi.org/10.3389/fneur.2021.666491.
[11] LIAO J N,CHAO T F,CHEN S A. How do aging and comorbidities impact risk of ischemic stroke in patients with atrial fibrillation[J]. Trends Cardiovasc Med,2019,29(7):386-391.
[12] GUROL M E,WRIGHT C B,JANIS S,et al. Stroke prevention in atrial fibrillation:our current failures and required research[J]. Stroke,2024,55(1):214-225.
[13] SPOSATO L A,FIELD T S,SCHNABEL R B,et al. Towards a new classification of atrial fibrillation detected after a stroke or a transient ischaemic attack[J]. Lancet Neurol,2024,23(1):110-122.
[14]KAMEL H. Reassessing the implications of atrial fibrillation detected after stroke[J]. Lancet Neurol,2024,23(1):9-11.
[J]. Chinese Journal of Stroke, 2024, 19(8): 924-930.
[12]
LU Dan, CHEN Weiqi, WANG Yaping, DUAN Wanying, GUO Lei, WANG Ling, LIU Liping, XU Anding, WANG Yongjun, Cerebroprotection Academic Roundtable Academic Committee of Chinese Stroke Association .